SOS1- and KRAS-driven Tumors
Part of Oncology
🏥2Companies
❤️1Engagements
Companies in SOS1- and KRAS-driven Tumors
Schrödinger
New York, New York, United States
Schrödinger is an international scientific software and biotechnology company, founded in 1990, developing computational tools for drug discovery and materials science. Its phys...
...moreBusiness ModelB2B (Software licensing) and a drug discovery model, advancing preclinical and clinical programs internally and through collaborations. SaaS is implied through platform licensing.
Core Techphysics-based computational platform
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowFounded1990
Drug Discovery/Development
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowBaobab AiBio (바오밥에이바이오)
Incheon, South Korea
The KRAS mutation is an oncogene that is common in all human cancers, and it is known that the incidence of mutation is high in major cancers such as pancreatic cancer, colon ca...
...moreFounded2018
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now